Research & Development

Can Bovine H5N1 Mutations Lead to Human Adaptation and Transmission?
Research & Development Can Bovine H5N1 Mutations Lead to Human Adaptation and Transmission?

The emergence of highly pathogenic avian influenza (HPAI) H5N1 in 1996 marked a significant event in the history of infectious diseases. Over the years, this virus has spread across continents, infecting various species and creating diverse clades. The potential for H5N1 to adapt to humans through

Can EZH2 Inhibitors Enhance Immunotherapy for B-cell Lymphomas?
Research & Development Can EZH2 Inhibitors Enhance Immunotherapy for B-cell Lymphomas?

Recent research from Weill Cornell Medicine has unveiled a promising preclinical discovery that could significantly enhance the effectiveness of cancer immunotherapy for B-cell non-Hodgkin lymphomas (B-NHL). The study focuses on the use of EZ## inhibitors, an emerging class of anticancer drugs, in

Advancements and Challenges in Drug Addiction Treatment Strategies
Research & Development Advancements and Challenges in Drug Addiction Treatment Strategies

Drug addiction has been a persistent issue throughout human history, documented from ancient times. Traditionally viewed as a moral failing rather than a treatable disease, the perception of addiction began to shift in the 20th century with scientific discoveries highlighting its basis in brain

How Will the New HWE Reaction Advance Anti-Cancer Drug Development?
Research & Development How Will the New HWE Reaction Advance Anti-Cancer Drug Development?

The field of organic chemistry has witnessed a significant breakthrough with the development of a highly (E)-selective Weinreb amide-type Horner–Wadsworth–Emmons (HWE) reaction. This advancement was achieved by a team from the Department of Applied Chemistry at Tokyo University of Science (TUS) in J

Innovative Cell-Based Immunotherapy Reduces Tumors in Breast Cancer Trial
Research & Development Innovative Cell-Based Immunotherapy Reduces Tumors in Breast Cancer Trial

In a remarkable breakthrough in breast cancer treatment, a novel cell-based immunotherapy developed by Dr. Gary Koski from Kent State University and Dr. Brian J. Czerniecki from the Moffitt Cancer Center has been recently accepted for publication in JAMA Oncology. This innovative approach harnesses

Breakthrough Gene Therapy Could Prevent Premature Births Worldwide
Research & Development Breakthrough Gene Therapy Could Prevent Premature Births Worldwide

A groundbreaking gene therapy showing promise in preventing premature births and treating placental growth insufficiency holds the potential to significantly improve pregnancies worldwide. This revolutionary therapy is being developed by a dedicated team led by Dr. Helen N. Jones from the

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later